发明申请
- 专利标题: NOVEL TRICYCLIC COMPOUNDS
- 专利标题(中): 新型三聚体化合物
-
申请号: US14610119申请日: 2015-01-30
-
公开(公告)号: US20150210708A1公开(公告)日: 2015-07-30
- 发明人: Neil Wishart , Maria A. Argiriadi , David J. Calderwood , Anna M. Ericsson , Bryan A. Fiamengo , Kristine E. Frank , Michael M. Friedman , Dawn M. George , Eric R. Goedken , Nathan S. Josephsohn , Biqin C. Li , Michael J. Morytko , Kent D. Stewart , Jeffrey W. Voss , Grier A. Wallace , Lu Wang , Kevin R. Woller
- 申请人: AbbVie Inc.
- 申请人地址: US IL North Chicago
- 专利权人: AbbVie Inc.
- 当前专利权人: AbbVie Inc.
- 当前专利权人地址: US IL North Chicago
- 主分类号: C07D487/14
- IPC分类号: C07D487/14
摘要:
The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
公开/授权文献
- US09365579B2 Tricyclic compounds 公开/授权日:2016-06-14